Back to Authors

Pendlebury, Devon F.

A5048347620 | I4210146710

Mayo Clinic in Florida

Citations 1

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers

Oncotarget | October 4, 2015 | Volume: 6 | Issue: 34 | Pages: 35737-35754

10.18632/oncotarget.5927 | PMID 26437224